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Purpose: To determine whether the ocular surface inflammation in uveitis mimics or counteracts intraocular inflammatory
pathways by directly comparing T-helper (Th) lymphocytes Th1 and Th2 markers in conjunctival and ciliary body
expression in endotoxin-induced uveitis (EIU). This study used the following inflammatory markers: chemokine receptor,
CC chemokine receptor 4 (CCR4), and its ligand, macrophage-derived chemokine (MDC), to evaluate Th2 participation;
chemokine receptor, CCR5, to evaluate the Th1 system; and its ligand, regulated on activation normal T cell expressed
and secreted (RANTES), to evaluate both Th1 and Th2 systems.
Methods: Immunohistochemistry and real-time polymerase chain reaction (RT–PCR) were used to compare protein and
RNA expression of CCR4, MDC, CCR5, and RANTES in the conjunctiva and ciliary body in EIU 6 h and 24 h after the
lipopolysaccharide (LPS) injection and in control (without injection) Lewis rats.
Results: Immunohistochemistry with CCR5, RANTES, and MDC showed an increase in fluorescent staining in the
conjunctiva and ciliary body in the rats with uveitis compared to the control rats. For CCR4, immunostaining was
comparable in the conjunctiva and ciliary body and did not show any clear differences between control rats and rats with
EIU. For RANTES, MDC, and CCR5, RT-PCR showed a significantly higher RNA expression in conjunctiva and in ciliary
body at 6 h compared to 24 h and controls. For CCR4, RT-PCR did not illustrate any significant differences in conjunctiva
and in ciliary body between all groups of animals.
Conclusions: Protein and RNA expressions of RANTES, MDC, and CCR5 were higher in EIU rats than in control rats
in the conjunctiva and ciliary body whereas the CCR4 level was not modified in the conjunctiva and ciliary body of EIU
rats when compared to controls. Th1 activation seemed to predominate in this model with high levels of CCR5 expression
and no increased expression of CCR4, but Th2 participation with MDC was noted. The expression of RANTES, MDC,
CCR4 and CCR5 in EIU was quite similar between the conjunctiva and the ciliary body, so conjunctival inflammation
might reproduce the intraocular inflammation, probably generated by local extension and diffusion in this model. If the
ocular surface mimics intraocular inflammatory pathways, the conjunctiva may provide a new and easier access for uveitis
studies.
Uveitis is an ophthalmologic entity comprising several
heterogeneous  diseases,  all  characterized  by  intraocular
inflammation starting initially in the uvea [1,2]. The different
immune pathways involved in this process have not yet been
thoroughly  described.  The  participation  of  T-helper
lymphocytes seems to predominate in uveitis as shown by
analyses of intraocular fluids of patients with uveitis [3,4]. T-
helper (Th) lymphocytes are classically composed of two
subsets, Th1 and Th2, differentiated by the type of cytokines
they secrete [5,6]. A new lineage of T cells, called Th17,
which  produces  the  cytokine,  interleukin-17  (IL-17),  has
recently been described [7]. Th17 might be involved in the
pathophysiology of experimental autoimmune uveitis (EAU),
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and Th1 could play a regulation role toward Th17 through its
production of IL-27, which inhibits the secretion of IL-17 [8,
9]. Th17 may play a central role in uveitis, but its function and
interaction with Th1 remain to be clarified [10,11]. The Th1
response  classically  plays  a  central  role  in  the
immunopathological  process  of  experimental  autoimmune
uveitis [2,12]. Analyses of intraocular fluids in human uveitis
tend to favor Th1 involvement because they showed Th1
cytokines such as interferon-gamma. However, to date, the
analyses have been unable to define a clear predominance of
Th1 or Th2 responses [2-4]. Ocular inflammation primarily
involves the uveal tract but can also extend to other ocular
structures such as the retina or vitreous. The involvement of
the conjunctiva in uveitis has not been studied as much. Little
is known about inflammation occurring on the ocular surface
of  uveitic  patients  [13,14],  but  conjunctival  injection  is
frequently observed in anterior uveitis [1].
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2428Our  laboratory  developed  new,  noninvasive,  and
objective  techniques  to  explore  immunoinflammatory
markers  expressed  on  the  ocular  surface  by  conjunctival
epithelial cells, using flow cytometry in impression cytology
specimens [15] in a variety of ocular surface diseases [16].
Recently,  our  group  has  investigated  the  Th1  and  Th2
inflammatory cascades by assessing CC chemokine receptor
4 (CCR4) and CCR5 expression in conjunctival cells in uveitis
[17]. Indeed, CCR4 and CCR5 are known to be chemokine
receptors related to the Th2 and Th1 systems, respectively.
Their principal ligands are CC chemokine ligand 3(CCL3)/
macrophage  inflammatory  protein  1α  (MIP-1α),  CCL4/
MIP-1β,  and  CCL5/regulated  on  activation  normal  T  cell
expressed and secreted (RANTES), for CCR4, and CCL17/
thymus  and  activation-regulated  chemokine  (TARC)  and
CCL22/macrophage-derived  chemokine  (MDC),  for
CCR5.MIP-1α is a chemokine that binds receptors of Th1 cell
lines, TARC and MDC are related to Th2 and MIP-1β, and
RANTES binds receptors of both Th1 and Th2 cell lines [18,
19]. CCR4 was overexpressed in the epithelial conjunctival
cells of uveitis, and its overexpression suggested involvement
of the Th2 system on the ocular surface while participation of
Th1  is  usually  considered  to  be  favored  in  intraocular
pathogenesis, at least in experimental autoimmune uveitis
[6]. This previous study suggested that there may be striking
differences in inflammatory pathways between intraocular
tissues  and  the  ocular  surface.  Therefore,  each  may  react
differently to immunogenic inflammation. The aim of the
current study was to determine whether the ocular surface
mimics or counteracts intraocular inflammatory pathways by
directly  comparing  Th1  and  Th2  markers  between  the
conjunctiva (ocular surface component) and the ciliary body
(representing intraocular structures) in an experimental model
of uveitis, endotoxin-induced uveitis (EIU). This model of
acute ocular inflammation has been used for some forms of
human  anterior  uveitis  [20]  and  the  inflammatory  cell
infiltrate of the anterior segment is maximal at 24 h after
lipopolysaccharide (LPS) injection [21]. In this study, these
different inflammatory markers were used to asses Th1 or Th2
activation: chemokine receptor CCR4 and its ligand MDC, for
Th2 participation; but also chemokine receptor, CCR5, for
Th1 system; and at last its ligand, RANTES, for both the Th1
and  Th2  systems.  Immunohistochemistry  and  real-time
polymerase chain reaction (PCR) were used to compare the
protein  and  RNA  expression  of  these  markers  in  the
conjunctiva and ciliary bodies in EIU 6 h and 24 h after LPS
injection.
METHODS
Animal  groups  and  endotoxin-induced  uveitis  induction:
Eighteen  inbred,  male,  adult  Lewis  rats  (8-10  weeks  old;
Centre d’élevage R. Janvier, Le Genest-St-Isle, France) were
used. All animals were treated according to the Association
for Research in Vision and Ophthalmology Resolution on the
Human  Use  of  Animals  in  Vision  Research  under  the
supervision  of  an  independent  health  authority-accredited
staff member for animal care and management.
Lipopolysaccharide (LPS) from Escherichia coli (Sigma
Chemical, St Louis, MO) was dissolved in sterile pyrogen-
free saline at 1 mg/ml. Uveitis was induced with a single 150
μ
g subcutaneous injection of LPS solution (1 mg/ml). Rats
were divided into two different groups, one for histologic and
immunohistochemical studies and the other for PCR analyses.
Each group was composed of three subgroups of three rats (a
total of nine rats per group). The first subgroup contained three
control rats that were not injected, the second group was made
up of three rats injected with LPS and sacrificed at 6 h, and
the third subgroup consisted of three rats sacrificed 24 h after
LPS  injection.  Rats  were  euthanized  with  an  injection  of
pentobarbital (sodium pentobarbital, Ceva Santé Animale,
Libourne, France) at a lethal dose.
Histologic  examination:  After  euthanasia,  the  eyes  were
enucleated, placed in the optimal cutting temperature (OCT)
compound (Tissue-Tek, Zoeterwoude, the Netherlands), and
snap  frozen.  Seven  micrometer  frozen  antero-posterior
sections were prepared at the optic nerve level on gelatin-
coated slides for histological analysis. Sections were fixed in
4% paraformaldehyde for 5 min at room temperature and
stained  with  hematoxylin  and  eosin  (HE).  To  study  the
modification of the conjunctival architecture and infiltration
of inflammatory cells in EIU, conjunctival epithelium and
stroma were examined under the light microscope with high
power  objectives  (Leica  Aristoplan;  Leica  Microsystemes
SAS, Rueil-Malmaison, France).
Immunohistochemistry:  After  sacrifice,  the  animals  were
enucleated,  and  the  eyes  were  embedded  in  the  OCT
compound and snap frozen. Seven micrometer frozen antero-
posterior sections were prepared at the optic nerve level on
gelatin-coated slides for immunohistochemical analysis.
Sections were fixed in 4% paraformaldehyde for 20 min
at room temperature, rinsed with phosphate buffered saline
(PBS), and incubated in 1% Triton X-PBS (Sigma Chemical)
for 20 min. After washing with PBS, sections were incubated
at 4 °C overnight with one of the following specific primary
antibodies diluted (1:50) in PBS containing 1% human serum
albumin (Sigma Chemical) to saturate nonspecific fixation
sites:
-Monoclonal  mouse  anti-rat  CCR5  (Santa  Cruz
Biotechnology, Santa Cruz, CA);
-Polyclonal  goat  anti-rat  CCR4  (Santa  Cruz
Biotechnology);
-Polyclonal  goat  anti-rat  MDC  (Santa  Cruz
Biotechnology);
-Polyclonal  goat  anti-rat  RANTES  (Santa  Cruz
Biotechnology;
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-Immunoglobulin IgG1 mouse antibody for isotypic
control (Serotec, Oxford, UK).The sections were rinsed twice for 5 min with PBS after
incubation  with  specific  primary  antibodies  and  then
incubated  for  1  h  at  room  temperature  with  secondary
antibodies, depending of the nature of the primary antibodies.
The secondary antibodies used were Alexa Fluor 488 goat
anti-mouse IgG (diluted 1:200; Invitrogen, Eugene, OR) and
Alexa  Fluor  488  rabbit  anti-goat  IgG  (diluted  1:100;
Invitrogen) in PBS containing 1% human serum albumin.
After two washes with PBS, sections were counter-stained for
5 min with propidium iodide (Sigma Chemical), rinsed with
PBS for 5 min, and mounted with Vectashield H1000 (Vector
Laboratories, Burlingame, CA). The slides were examined
with a confocal microscope (Nikon PCM 2000; Nikon France,
Champigny-sur-Marne, France).
Semi-quantitative  reverse  transcription  and  real-time
polymerase chain reaction: The conjunctiva and ciliary body
of the enucleated eyes of control rats and the experimental rats
6 h and 24 h after LPS injection were dissected separately to
compare  RNA  expression  of  RANTES,  MDC,  CCR4,  and
CCR5. Total RNA was isolated with the RNeasy Mini Kit
(Qiagen,  Courtaboeuf,  France).  For  each  sample,  single-
stranded  cDNA  was  synthesized  from  total  RNA  using
dNTPs, random primers, and superscript reverse transcriptase
(Invitrogen).  RT–PCR  was  performed  using  cDNA  and
RANTES,  MDC,  CCR4,  CCR5,  and  GAPDH
(glyceraldehyde-3-phosphate  dehydrogenase)  as  the
endogenous control. TaqMan probes were purchased from
Applied Biosystems (Foster City, CA). PCR reactions were
performed for 40 cycles (denaturation at 95 °C for 15 s and
elongation at 60 °C for 45 s) in a thermal cycler (model 7300
SDS; Applied Biosystems). The comparative threshold (Ct)
cycle method was used for the relative quantification of gene
expression  with  the  RT–PCR  data.  The  Cts  of  RANTES,
MDC, CCR4, and CCR5 were normalized to the levels of the
endogenous  control  GAPDH  at  each  time  after  the  LPS
injection. The degree of change in each gene was calculated
and compared with the control rats.
Statistical  analysis:  The  variance  was  analyzed  using  the
Kruskal–Wallis test, and then the data were compared with
the  Mann–Whitney  statistical  test.  The  differences  were
judged significant when p<0.05.
RESULTS
Histological  analysis:  Histological  analysis  of  antero-
posterior  sections  24  h  after  the  LPS  injection  showed
disorganization of the epithelial architecture with an increase
in the number of layers and the size of epithelial cells (Figure
1).
Immunohistochemical analysis: Immunohistochemistry with
RANTES,  MDC,  and  CCR5  showed  a  slight  increase  in
fluorescent staining intensity (in green) in the conjunctival
epithelium and in the ciliary body of the rats with uveitis with
a  peak  at  24  h  after  the  LPS  injection  (Figure  2)  when
compared to the control rats. For CCR4, immunostaining (in
green) was strong but comparable in the conjunctiva and the
ciliary body and did not show any clear difference between
control rats and rats with EIU (Figure 3).
Figure  1.  Histological  micrographs.
Conjunctiva  in  control  rats  with  10X
(A)  and  50X  (B)  enlargement.
Conjunctiva  in  endotoxin-induced
uveitis (EIU) 24 h after LPS injection
with  10X  (C)  and  a  50X  (D)
enlargement showed a disorganization
of  the  epithelial  architecture  with  an
increase in the number of layers and the
size of epithelial cells
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chain reaction: To quantify RNA expression of RANTES,
MDC, CCR4, and CCR5 in the conjunctiva and ciliary body,
reverse transcription polymerase chain reaction (RT–PCR)
was performed on conjunctival and ciliary body extracts from
controls and rats with EIU at 6 h and 24 h. RNA expression of
RANTES, MDC, and CCR5 in the conjunctiva and ciliary body
was significantly higher in EIU rats at 6 h than in EIU rats at
24 h and in control rats (Figure 4 and Figure 5). For CCR4,
there was no significant difference in the conjunctiva and in
ciliary body between the controls and the EIU rats at 6 h and
24 h (Figure 5).
DISCUSSION
Expression of the inflammatory markers, RANTES, MDC,
CCR5, and CCR4, was analyzed in the conjunctiva and ciliary
bodies using two different techniques, immunostaining and
molecular  biology.  A  positive  staining  in
immunohistochemistry was observed with all the markers
studied in the conjunctiva and ciliary body of EIU rats, but
this technique provided more qualitative than quantitative
Figure 2. Immunostaining in a model of
endotoxin-induced  uveitis  analyzed
with a confocal microscope with 20X
enlargement. Conjunctivas stained with
anti-CCR5 antibody were revealed with
secondary  antibody,  Alexa  Fluor  (in
green),  while  nuclear  chromatin  was
stained with propidium iodide (in red) in
control rats (A) and in EIU rats 6 h (B)
and 24 h (C) after LPS injection. Ciliary
bodies  were  stained  with  the  same
antibodies in control rats (D) and in EIU
rats  6  h  (E)  and  24  h  (F)  after  LPS
injection. CCR5 expression (in green)
was higher in the conjunctiva and ciliary
bodies of the rats with EIU than of the
controls.
Figure  3.  CCR4  immunostaining  of
conjunctiva  and  ciliary  bodies  in  a
model  of  endotoxin-induced  uveitis
analyzed  with  a  confocal  microscope
with 20X enlargement. Conjunctiva was
stained  with  CCR4  (in  green)  and
propidium iodide for nuclei (in red) in
control rats (A) and of EIU rats 6 h (B)
and  24  h  (C)  after  LPS  injection.
Staining  of  ciliary  bodies  was
performed in control rats (D) and in EIU
rats  at  6  h  (E)  and  24  h  (F).
Immunostaining (in green) was positive
in  all  cases  but  comparable  in  the
conjunctiva  and  the  ciliary  body.
Immunostaining did not show any clear
differences between control rats and rats
with EIU.
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2431analyses  of  chemokines  and  chemokine  receptors.  To
compare  the  level  of  expression  of  these  markers,  we
combined  the  molecular  biology  technique  with  semi-
quantitative real-time PCR since it is a more precise tool to
quantify gene expression. In our study, semi-quantitative PCR
confirmed the immunostaining results. Indeed, the protein and
RNA expressions of RANTES, MDC, and CCR5 were higher
in the conjunctiva and ciliary body of EIU rats (at 6 h and 24
h)  than  of  the  control  rats  on.  In  immunohistochemistry,
RANTES, MDC, and CCR5 expressions peaked 24 h after the
LPS injection while in PCR, their RNA expression peaked at
6 h. The time difference between the peak of protein and RNA
expression  could  be  explained  by  the  time  needed  to
synthesize protein from RNA. Both methods found that there
were no differences in the CCR4 level between EIU rats and
controls, which is quite different from our previous report in
humans [17] where CCR4 was overexpressed by conjunctival
epithelial cells. This difference is probably explained by the
fact that EIU is a quickly systemic induced, short-term uveitis
model that does not fully reproduce the complexity of human
uveitis.. In this model, it is possible that in addition to the local
ocular inflammation, there is an upregulation of epithelial
cells  by  LPS  systemic  stimulation,  which  could  therefore
corroborate to our results published in patients with uveitis.
Nevertheless,  our  goal  was  to  compare  surface  and  uvea
immunopathological changes, and this model showed that
expression of RANTES, MDC, CCR4, and CCR5 in EIU was
quite similar in the conjunctiva and ciliary body, indicating
that  conjunctival  inflammation  might  reproduce  the
intraocular  inflammation  generated  in  this  uveitis  model
probably by local extension and diffusion. This study showed
an overexpression of RANTES, MDC, and CCR5 in EIU
animals  compared  to  controls  and  confirmed  previous
publications in which RANTES was found by RT–PCR in the
ciliary body in EIU animals [22,23]. In the literature, high
levels of interleukin-1 (IL-1), IL-6, IL-10, tumor necrosis
factor  (TNF)-α,  RANTES,  interferon  (IFN)-γ,  monocyte
chemotactic  protein  1  (MCP-1),  and  macrophage
inflammatory protein 2 (MIP-2) were found in EIU animals
[21-26]. Therefore, Th1 and Th2 cytokine profiles in EIU have
not  been  well  defined,  probably  because  inflammatory
pathways in EIU mostly involve neutrophils and macrophages
[27-29]. Nevertheless, lymphocytes also infiltrate the iris and
ciliary  body  and  seem  to  have  a  fundamental  role  in  the
pathogenesis of EIU [27,30,31], so discrimination of Th1/Th2
systems  should  be  helpful  in  understanding  lymphocyte
functions in EIU. In our study, Th1 activation seemed to
predominate  in  this  model  with  high  levels  of  CCR5
overexpression and no increased expression of CCR4, but Th2
participation with MDC was also noted. The Th1 response is
usually thought to play a central role in other animal model
studies of uveitis. Indeed, in experimental autoimmune uveitis
(EAU), which is a Th1 inflammation induced by a retinal
antigen,  Th1  participation  is  recognized  [2]  with  the
overexpression of chemokines related to the Th1 system such
as MIP-1 α and RANTES as well as the chemokine receptor,
Figure  4.  Quantification  of  mRNA
expression  of  RANTES  and  MDC  in
conjunctiva and ciliary bodies by real
time-PCR. mRNA expression levels of
RANTES and MDC normalized to the
levels  of  the  endogenous  control,
GAPDH,  were  quantified  in  the
conjunctiva (A) and ciliary bodies (B) of
control rats and of rats with EIU 6 h and
24  h  after  LPS  injection  using  semi-
quantitative real-time PCR. Data shown
are the mean±SD. An asterisk indicates
that  there  is  a  significant  difference
between the control rats and the rats with
EIU at 24 h (p<0.05).
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2432CCR5 [32]. In the current study, the analysis of chemokines
and chemokine receptors in EIU partially confirmed the Th1
activation in the immunopathological process of EAU. There
was  no  difference  for  the  expression  of  the  Th2-specific
chemokine receptor, CCR4, between the EIU and control
animals in our study, which is similar to findings for EAU
where low levels of CCR4 were found [33].
In  conclusion,  chemokine  and  chemokine  receptor
analysis  showed  that  inflammation  on  the  ocular  surface
reproduced  intraocular  phenomena  by  extension  in  this
experimental model of uveitis, EIU. Further studies on human
uveitis  and  other  experimental  models  of  uveitis  could
compare the chemokine profile in intraocular fluid and ocular
surface  samples.  If  the  ocular  surface  mimics  intraocular
inflammatory pathways, the conjunctiva could provide a new
and easier access for uveitis studies with less invasive exams
than anterior chamber paracentesis or vitrectomy samples.
Chorioretinal biopsies, like conjunctival impressions, could
be  developed  to  investigate  inflammatory  activity  and
pathophysiological mechanisms in uveitis.
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